Apoptosis: A way to maintain healthy individuals

Sub-Cellular Biochemistry

Volumn 50, Issue , 2010, Pages 307-323

  Mondello, Chiara ^b   Scovassi1, Ivana A ^a  

^a CNR   (Italy)

^b NONE

Author keywords

Aneuploidy; Apoptosis; Cancer; Development; Genome instability

Indexed keywords

APOPTOSIS; DNA REPAIR; DNA REPLICATION; EMBRYO DEVELOPMENT; HUMAN; REVIEW;

APOPTOSIS; DNA REPAIR; DNA REPLICATION; EMBRYONIC DEVELOPMENT; HUMANS;

EID: 77952982790     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-90-481-3471-7_16     Document Type: Article

References (121)

1. Andersen, J. K. (2001) Does neuronal loss in Parkinson’s disease involve programmed cell death? Bioessays, 23, 640–646
2. Baek, K. H., Shin, H. J., Jeong, S. J., Park, J. W., McKeon, F., Lee, C. W., and Kim, C. M. (2005) Caspases-dependent cleavage of mitotic checkpoint proteins in response to microtubule inhibitor. Oncol Res, 15, 161–168
3. Bernardi, R., Negri, C., Donzelli, M., Guano, F., Torti, M., Prosperi, E., and Scovassi, A. I. (1995) Activation of poly(ADP-ribose)polymerase in apoptotic human cells. Biochimie, 77, 378–384
4. Bidere, N., Su, H. C., and Lenardo, M. J. (2006) Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol, 24, 321–352
5. Boekelheide, K., Fleming, S. L., Johnson, K. J., Patel, S. R., and Schoenfeld, H. A. (2000) Role of Sertoli cells in injury-associated testicular germ cell apoptosis. Proc Soc Exp Biol Med, 225, 105–115
6. Bottger, A. and Alexandrova, O. (2007) Programmed cell death in Hydra. Semin Cancer Biol, 17, 134–146
7. Brito, D. A. and Rieder, C. L. (2006) Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol, 16, 1194–1200
8. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature, 392, 300–303
9. Call, J. A., Eckhardt, S. G., and Camidge, D. R. (2008) Targeted manipulation of apoptosis in cancer treatment. Lancet Oncol, 9, 1002–1011
10. Cecconi, F. and Levine, B. (2008) The role of autophagy in mammalian development: cell makeover rather than cell death. Dev Cell, 15, 344–357
11. Cecconi, F., Piacentini, M., and Fimia, G. M. (2008) The involvement of cell death and survival in neural tube defects: a distinct role for apoptosis and autophagy? Cell Death Differ, 15, 1170–1177
12. Chandhok, N. S. and Pellman, D. (2009) A little CIN may cost a lot: revisiting aneuploidy and cancer. Curr Opin Genet Dev, 19, 74–81
13. Checchi, P. M., Nettles, J. H., Zhou, J., Snyder, J. P., and Joshi, H. C. (2003) Microtubule-interacting drugs for cancer treatment. Trends Pharmacol Sci, 24, 361–365
14. Chiarugi, A. (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol Sci, 23, 122–129
15. Counis, M. F. and Torriglia, A. (2006) Acid DNases and their interest among apoptotic endonucle-ases. Biochimie, 88, 1851–1858
16. de Felici, M., Lobascio, A. M., and Klinger, F. G. (2008) Cell death in fetal oocytes: many players for multiple pathways. Autophagy, 4, 240–242
17. Degrassi, F., Fiore, M., and Palitti, F. (2004) Chromosomal aberrations and genomic instability induced by topoisomerase-targeted antitumour drugs. Curr Med Chem Anticanc Agents, 4, 317–325
18. Degterev, A. and Yuan, J. (2008) Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol, 9, 378–390
19. Duesberg, P. (2007) Chromosomal chaos and cancer. Sci Am, 296, 52–59
20. Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol, 7, 663–698
21. Erwig, L. P. and Henson, P. M. (2007) Immunological consequences of apoptotic cell phagocytosis. Am J Pathol, 171, 2–8
22. Fadeel, B. and Orrenius, S. (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med, 258, 479–517
23. Fan, Y. and Bergmann, A. (2008) Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell! Trends Cell Biol, 18, 467–473
24. Fink, S. L. and Cookson, B. T. (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun, 73, 1907–1916
25. Frouin, I. and Scovassi, A. I. (2008) Poly(ADP-ribosylation) regulates DNA replication and repair. In: Maga G., Hübscher, U. and Villani, G. (Eds.) DNA Replication Repair and Recombination at the Crossroad Between Genome Integrity and Genomic Instability: A Biochemical Perspective, Research Signpost, Kerala, India, pp. 116–130
26. Gartner, A., Boag, P. R., and Blackwell, T. K. (2008) Germline survival and apoptosis. WormBook, 1–20
27. Ghafari, F., Gutierrez, C. G., and Hartshorne, G. M. (2007) Apoptosis in mouse fetal and neonatal oocytes during meiotic prophase one. BMC Dev Biol, 7, 87
28. Giansanti, V. and Scovassi, A. I. (2008a) Apoptosis and cancer. In: Mondello C. (Ed.) Multiple Pathways in Cancer Development, Transworld Research Network, Kerala, India, pp. 135–147
29. Giansanti, V. and Scovassi, A. I. (2008b) Cell death: a one-way journey to the graveyard. Open Biol J, 1, 27–34
30. Gil, J. M. and Rego, A. C. (2008) Mechanisms of neurodegeneration in Huntington’s disease. Eur J Neurosci, 27, 2803–2820
31. Giovannetti, A., Pierdominici, M., Di Iorio, A., Cianci, R., Murdaca, G., Puppo, F., Pandolfi, F., and Paganelli, R. (2008) Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr Pharm Des, 14, 253–268
32. Gougeon, M. L. (2003) Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol, 3, 392–404
33. Gougeon, M. L. and Montagnier, L. (1992) New concepts in the mechanisms of CD4+ lymphocyte depletion in Aids, and the influence of opportunistic infections. Res Microbiol, 143, 362–368
34. Gougeon, M. L. and Montagnier, L. (1993) Apoptosis in AIDS. Science, 260, 1269–1270
35. Green, D. R. (2005) Apoptotic pathways: ten minutes to dead. Cell, 121, 671–674
36. Gregory, C. D. and Brown, S. B. (2005) Apoptosis: eating sensibly. Nat Cell Biol, 7, 1161–1163
37. Ha, G. H., Baek, K. H., Kim, H. S., Jeong, S. J., Kim, C. M., McKeon, F., and Lee, C. W. (2007) p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation. Cancer Res, 67, 7155–7164
38. Hassa, P. O. (2009) The molecular “Jekyll and Hyde” duality of PARP1 in cell death and cell survival. Front Biosci, 14, 72–111
39. Hay, B. A. and Guo, M. (2006) Caspase-dependent cell death in Drosophila. Annu Rev Cell Dev Biol, 22, 623–650
40. Hong, Y., Cervantes, R. B., Tichy, E., Tischfield, J. A., and Stambrook, P. J. (2007) Protecting genomic integrity in somatic cells and embryonic stem cells. Mutat Res, 614, 48–55
41. Jaattela, M. (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res, 248, 30–43
42. Jaattela, M. (2004) Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene, 23, 2746–2756
43. Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Programmed cell death in animal development. Cell, 88, 347–354
44. Jeggo, P. A. (1998) DNA repair: PARP – another guardian angel?. Curr Biol, 8, R49–R51
45. Johnson, L., Thompson, D. L., Jr., and Varner, D. D. (2008) Role of Sertoli cell number and function on regulation of spermatogenesis. Anim Reprod Sci, 105, 23–51
46. Kanai, M., Hanashiro, K., Kim, S. H., Hanai, S., Boulares, A. H., Miwa, M., and Fukasawa, K. (2007) Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol, 9, 1175–1183
47. Kaufmann, S. H. (1998) Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta, 1400, 195–211
48. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26, 239–257
49. Kim, M., Liao, J., Dowling, M. L., Voong, K. R., Parker, S. E., Wang, S., El-Deiry, W. S., and Kao, G. D. (2008) TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells. Cancer Res, 68, 3440–3449
50. Kim, M., Murphy, K., Liu, F., Parker, S. E., Dowling, M. L., Baff, W., and Kao, G. D. (2005) Caspase-mediated specific cleavage of BubR1 is a determinant of mitotic progression. Mol Cell Biol, 25, 9232–9248
51. Kim, M. R. and Tilly, J. L. (2004) Current concepts in Bcl-2 family member regulation of female germ cell development and survival. Biochim. Biophys Acta, 1644, 205–210
52. Kobayashi, Y. and Yonehara, S. (2009) Novel cell death by downregulation of eEF1A1 expression in tetraploids. Cell Death Differ, 16, 139–150
53. Kotani, S., Tanaka, H., Yasuda, H., and Todokoro, K. (1999) Regulation of APC activity by phosphorylation and regulatory factors. J Cell Biol, 146, 791–800
54. Kumar, S. (2007) Caspase function in programmed cell death. Cell Death Differ, 14, 32–43
55. Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643–649
56. Letai, A. G. (2008) Diagnosing and exploiting cancer’s addiction to blocks in apoptosis. Nat Rev Cancer, 8, 121–132
57. Levine, B. and Kroemer, G. (2008) Autophagy in the pathogenesis of disease. Cell, 132, 27–42
58. Li, J. and Yuan, J. (2008) Caspases in apoptosis and beyond. Oncogene, 27, 6194–6206
59. Liu, Q., Hilsenbeck, S., and Gazitt, Y. (2003) Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Blood, 101, 4078–4087
60. Lockshin, R. A. and Zakeri, Z. (2004) Apoptosis, autophagy, and more. Int J Biochem Cell Biol, 36, 2405–2419
61. Luthi, A. U. and Martin, S. J. (2007) The CASBAH: a searchable database of caspase substrates. Cell Death Differ, 14, 641–650
62. Maiuri, M. C., Le Toumelin, G., Criollo, A., Rain, J. C., Gautier, F., Juin, P., Tasdemir, E., Pierron, G., Troulinaki, K., Tavernarakis, N., Hickman, J. A., Geneste, O., and Kroemer, G. (2007) Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J, 26, 2527–2539
63. Malanga, M. and Althaus, F. R. (2005) The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell Biol, 83, 354–364
64. Mathew, R., Kongara, S., Beaudoin, B., Karp, C. M., Bray, K., Degenhardt, K., Chen, G., Jin, S., and White, E. (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev, 21, 1367–1381
65. Mathew, R. and White, E. (2007) Why sick cells produce tumors: the protective role of autophagy. Autophagy, 3, 502–505
66. Mattson, M. P. (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol, 1, 120–129
67. Matulis, S. and Handel, M. A. (2006) Spermatocyte responses in vitro to induced DNA damage. Mol Reprod Dev, 73, 1061–1072
68. McClendon, A. K. and Osheroff, N. (2007) DNA topoisomerase Ii, genotoxicity, and cancer. Mutat Res, 623, 83–97
69. McNeely, S. C., Taylor, B. F., and States, J. C. (2008) Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicol Appl Pharmacol, 231, 61–67
70. Meraldi, P., Draviam, V. M., and Sorger, P. K. (2004) Timing and checkpoints in the regulation of mitotic progression. Dev Cell, 7, 45–60
71. Metzstein, M. M., Stanfield, G. M., and Horvitz, H. R. (1998) Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet, 14, 410–416
72. Meulmeester, E. and Jochemsen, A. G. (2008) p53: a guide to apoptosis. Curr Cancer Drug Targets, 8, 87–97
73. Montecucco, A. and Biamonti, G. (2007) Cellular response to etoposide treatment. Cancer Lett, 252, 9–18
74. Negri, C., Bernardi, R., Braghetti, A., Ricotti, G. C., and Scovassi, A. I. (1993) The effect of the chemotherapeutic drug VP-16 on poly(ADP-ribosylation) in apoptotic HeLa cells. Carcinogenesis, 14, 2559–2564
75. Negri, C., Bernardi, R., Donzelli, M., and Scovassi, A. I. (1995) Induction of apoptotic cell death by DNA topoisomerase II inhibitors. Biochimie, 77, 893–898
76. Niikura, Y., Dixit, A., Scott, R., Perkins, G., and Kitagawa, K. (2007) BUB1 mediation of caspase-independent mitotic death determines cell fate. J Cell Biol, 178, 283–296
77. Nutt, L. K., Margolis, S. S., Jensen, M., Herman, C. E., Dunphy, W. G., Rathmell, J. C., and Kornbluth, S. (2005) Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell, 123, 89–103
78. Oberst, A., Bender, C., and Green, D. R. (2008) Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ, 15, 1139–1146
79. Oei, S. L., Keil, C., and Ziegler, M. (2005) Poly(ADP-ribosylation) and genomic stability. Biochem Cell Biol, 83, 263–269
80. Panvichian, R., Orth, K., Day, M. L., Day, K. C., Pilat, M. J., and Pienta, K. J. (1998) Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance. Cancer Res, 58, 4667–4672
81. Penaloza, C., Orlanski, S., Ye, Y., Entezari-Zaher, T., Javdan, M., and Zakeri, Z. (2008) Cell death in mammalian development. Curr Pharm Des, 14, 184–196
82. Perera, D. and Freire, R. (2005) Human spindle checkpoint kinase Bub1 is cleaved during apoptosis. Cell Death Differ, 12, 827–830
83. Pietsch, E. C., Sykes, S. M., McMahon, S. B., and Murphy, M. E. (2008) The p53 family and programmed cell death. Oncogene, 27, 6507–6521
84. Ricke, R. M., van Ree, J. H., and van Deursen, J. M. (2008) Whole chromosome instability and cancer: a complex relationship. Trends Genet, 24, 457–466
85. Rieder, C. L. and Maiato, H. (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell, 7, 637–651
86. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol, 9, 402–412
87. Rodier, F., Campisi, J., and Bhaumik, D. (2007) Two faces of p53: aging and tumor suppression. Nucleic Acids Res, 35, 7475–7484
88. Rosen, A. and Casciola-Rosen, L. (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ, 6, 6–12
89. Rovere-Querini, P., Brunelli, S., Clementi, E., and Manfredi, A. A. (2008) Cell death: Tipping the balance of autoimmunity and tissue repair. Curr Pharm Des, 14, 269–277
90. Sawa, A. (1999) Neuronal cell death in Down’s syndrome. J Neural Transm Suppl, 57, 87–97
91. Schreiber, V., Dantzer, F., Ame, J. C., and de Murcia, G. (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol, 7, 517–528
92. Scovassi, A. I., Denegri, M., Donzelli, M., Rossi, L., Bernardi, R., Mandarino, A., Frouin, I., and Negri, C. (1998) Poly(ADP-ribose) synthesis in cells undergoing apoptosis: an attempt to face death before PARP degradation. Eur J Histochem, 42, 251–258
93. Scovassi, A. I. and Poirier, G. G. (1999) Poly(ADP-ribosylation) and apoptosis. Mol Cell Biochem, 199, 125–137
94. Scovassi, A. I. (2002) Multiple roles of poly ADP-ribosylation. Recent Res Devel Prot, 1, 345–360
95. Scovassi, A. I. and Torriglia, A. (2003) Activation of DNA-degrading enzymes during apoptosis. Eur J Histochem, 47, 185–194
96. Scovassi, A. I. and Diederich, M. (2004) Modulation of poly(ADP-ribosylation) in apoptotic cells. Biochem Pharmacol, 68, 1041–1047
97. Scovassi, A. I. (2005) Caspase-dependent apoptosis. In: Scovassi A. I. (ed.) Apoptosis, Research Signpost, Kerala, India, pp. 41–55
98. Scovassi, A. I. (2006) Apoptosis and cell death. In: Torriglia, A. and Lassiaz, P. (Eds.) Apoptosis in the Retina, Transworld Research Network, Kerala, India, pp. 1–11
99. Shi, Y. (2004) Caspase activation: revisiting the induced proximity model. Cell, 117, 855–858
100. Soldani, C., Lazze, M. C., Bottone, M. G., Tognon, G., Biggiogera, M., Pellicciari, C. E., and Scovassi, A. I. (2001) Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where?. Exp Cell Res, 269, 193–201
101. Soldani, C. and Scovassi, A. I. (2002) Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis, 7, 321–328
102. Sordet, O., Khan, Q. A., Kohn, K. W., and Pommier, Y. (2003) Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anticancer Agents, 3, 271–290
103. States, J. C., Reiners, J. J., Jr., Pounds, J. G., Kaplan, D. J., Beauerle, B. D., McNeely, S. C., Mathieu, P., and McCabe, M. J., Jr. (2002) Arsenite disrupts mitosis and induces apoptosis in SV40-transformed human skin fibroblasts. Toxicol Appl Pharmacol, 180, 83–91
104. Steller, H. (2008) Regulation of apoptosis in Drosophila. Cell Death Differ, 15, 1132–1138
105. Suijkerbuijk, S. J. and Kops, G. J. (2008) Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim Biophys Acta, 1786, 24–31
106. Takuma, K., Yan, S. S., Stern, D. M., and Yamada, K. (2005) Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer’s disease. J Pharmacol Sci, 97, 312–316
107. Tao, W., South, V. J., Zhang, Y., Davide, J. P., Farrell, L., Kohl, N. E., Sepp-Lorenzino, L., and Lobell, R. B. (2005) Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell, 8, 49–59
108. Thorburn, A. (2008) Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis, 13, 1–9
109. Tichy, E. D. and Stambrook, P. J. (2008) DNA repair in murine embryonic stem cells and differentiated cells. Exp Cell Res, 314, 1929–1936
110. Tilly, J. L. (2001) Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol, 2, 838–848
111. Vakifahmetoglu, H., Olsson, M., and Zhivotovsky, B. (2008) Death through a tragedy: mitotic catastrophe. Cell Death Differ, 15, 1153–1162
112. Vaux, D. L. and Korsmeyer, S. J. (1999) Cell death in development. Cell, 96, 245–254
113. Vazquez, A., Bond, E. E., Levine, A. J., and Bond, G. L. (2008) The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov, 7, 979–987
114. Vila, M. and Przedborski, S. (2003) Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci, 4, 365–375
115. Wiseman, F. K., Alford, K. A., Tybulewicz, V. L., and Fisher, E. M. (2009) Down syndrome–recent progress and future prospects. Hum Mol Genet, 18, R75–R83
116. Won, J., Chung, S. Y., Kim, S. B., Byun, B. H., Yoon, Y. S., and Joe, C. O. (2006) Dose-dependent UV stabilization of p53 in cultured human cells undergoing apoptosis is mediated by poly(ADP-ribosyl)ation. Mol Cells, 21, 218–223
117. Wu, Y. C., Yen, W. Y., and Yih, L. H. (2008) Requirement of a functional spindle checkpoint for arsenite-induced apoptosis. J Cell Biochem, 105, 678–687
118. Yih, L. H. and Lee, T. C. (2000) Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res, 60, 6346–6352
119. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345–347
120. Zakeri, Z. and Lockshin, R. A. (2002) Cell death during development. J Immunol Meth, 265, 3–20
121. Zhang, N., Hartig, H., Dzhagalov, I., Draper, D., and He, Y. W. (2005) The role of apoptosis in the development and function of T lymphocytes. Cell Res, 15, 749–769.